FDA WatchRead daily from FDA · recalls & warning letters

The recall that hits your shelf shouldn’t reach you from a customer.

FDA Watch reads every FDA recall, recall announcement, and warning letter, then emails you only the ones that touch your ingredients, products, and suppliers — explained in plain English, scored by severity.

No charge for 14 days · Set up your watchlist in 3 minutes

Powered by official public data: FDA recall announcements the day they post, openFDA drug, food, and device recalls, FDA warning letters, and California Board of Pharmacy actions against compounding pharmacies.

You set a watchlist once. We do the reading every day.

Most teams find out about a relevant recall too late — from a customer email, a retailer, or a lawyer. The data was public the whole time. It’s just buried in thousands of filings nobody has time to read.

  1. Tell us what you sell

    Add the ingredients, brand names, product types, and contract manufacturers you depend on. Edit anytime.

  2. AI reads every filing

    Each morning we pull new FDA recalls, recall announcements, and warning letters and match them against your watchlist — no keyword spam, real relevance scoring.

  3. You get only what matters

    A short email (and optional Slack ping) with the recall, why it matters to you, and a severity flag. Quiet days mean a quiet inbox.

FDA already emails recalls for free. Here’s what it doesn’t do.

FDA’s alerts are official and free. If a few keywords cover everything you sell, they may be all you need. If not, this is the difference.

FDA’s free email alertsFDA Watch
What gets matchedA topic, or the exact keywords you enter.Up to 50 ingredients, brands, and suppliers, and each match is checked by AI before it reaches you.
One recallCan reach you twice: the announcement email, then again in the Enforcement Report.When the announcement and the recall record name the same firm and product, you get one alert.
Warning lettersUpdates by topic, with no filter for your firms or ingredients.Each letter that touches your watchlist.
State boardsNot covered.California Board of Pharmacy actions against compounding pharmacies.
Your inboxA separate subscription for each feed.One morning digest. Quiet days stay quiet.
PriceFree.$49/mo founding rate, after 14 days free.

FDA Watch is independent and not affiliated with the FDA. FDA’s alerts as described on fda.gov, October 2026.

This is the whole product.

The morning email, exactly as it arrives: most severe first, each item explained against your own watchlist.

PublicRadar

2 items touched your watchlist today.

1 high · 1 medium · most severe first

High

Class I recall: Ashwagandha capsules recalled for undeclared lead

Herbal Wellness Labs is recalling 600mg ashwagandha root extract capsules nationwide after testing found lead above allowable limits. Status: ongoing.

Why it matters to you. Ashwagandha is on your watchlist and you use multiple extract suppliers — verify your lots and supplier are unaffected.

Medium

Class II recall: Collagen powder recalled for undeclared milk allergen

PureForm Nutrition recalled unflavored collagen peptide powder nationwide for an undeclared milk allergen on the label.

Why it matters to you. If you private-label from PureForm, this is an allergen-labeling exposure.

Sample alert. Companies, people, and figures are illustrative.

Cheaper than one afternoon of a recall fire-drill.

One plan, everything included. Start free for 14 days, cancel anytime. Built for supplement brands, compounding pharmacies, clinics, and contract manufacturers.

Standard

After the founding cohort

$99/mo

  • The regular price after the founding cohort
  • Up to 50 watchlist terms (ingredients, brands, suppliers)
  • Daily email digest + optional Slack
  • Drug, food & device recalls, plus recall announcements the day FDA posts them
  • FDA warning letters + California Board of Pharmacy actions
  • AI severity scoring + plain-English brief
Start free trial

FDA Watch surfaces publicly available FDA data for informational purposes only. Recalls, warning letters, and board actions are records, not adjudicated findings. This is not legal, medical, or regulatory advice — verify against primary FDA sources before acting.